标题
Aggressive multiple sclerosis: proposed definition and treatment algorithm
作者
关键词
-
出版物
Nature Reviews Neurology
Volume 11, Issue 7, Pages 379-389
出版商
Springer Nature
发表日期
2015-06-02
DOI
10.1038/nrneurol.2015.85
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
- (2015) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial
- (2015) G. L. Mancardi et al. NEUROLOGY
- High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
- (2015) Richard A. Nash et al. JAMA Neurology
- Management of relapsing–remitting multiple sclerosis in Latin America: Practical recommendations for treatment optimization
- (2014) Jorge Correale et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial
- (2014) Thomas P Leist et al. LANCET NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Disease Activity Free Status
- (2014) Carolyn J. Bevan et al. JAMA Neurology
- Results from the 5-year, phase IV RENEW (Registry to Evaluate Novantrone Effects in Worsening Multiple Sclerosis) study
- (2013) Victor M Rivera et al. BMC Neurology
- Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
- (2013) Gilles Edan et al. CNS DRUGS
- Autologous Hematopoietic Stem Cell Transplantation as a Treatment Option for Aggressive Multiple Sclerosis
- (2013) Nikolai Pfender et al. Current Treatment Options in Neurology
- Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS
- (2013) Jeffrey A. Cohen et al. JOURNAL OF NEUROLOGY
- Characterising aggressive multiple sclerosis
- (2013) Suresh Menon et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Rebound of Disease Activity After Withdrawal of Fingolimod (FTY720) Treatment
- (2012) Joachim B. Havla ARCHIVES OF NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper
- (2012) R Saccardi et al. Multiple Sclerosis Journal
- Withdrawal of fingolimod treatment for relapsing–remitting multiple sclerosis: report of six cases
- (2012) Bahia Hakiki et al. Multiple Sclerosis Journal
- Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned
- (2012) Harold L. Atkins et al. Neurotherapeutics
- Alemtuzumab Therapy for Multiple Sclerosis
- (2012) Alasdair J. Coles Neurotherapeutics
- Treatment of multiple sclerosis with Anti-CD20 antibodies
- (2011) Barbara Barun et al. CLINICAL IMMUNOLOGY
- Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial
- (2011) G. Edan et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Demographic and clinical characteristics of malignant multiple sclerosis
- (2011) T. Gholipour et al. NEUROLOGY
- Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
- (2011) M. Cossburn et al. NEUROLOGY
- Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
- (2011) P. W. O'Connor et al. NEUROLOGY
- Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated
- (2010) Joep Killestein et al. ANNALS OF NEUROLOGY
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis
- (2010) C. Lukas et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Poor recovery after the first two attacks of multiple sclerosis is associated with poor outcome five years later
- (2010) Thomas F. Scott et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
- (2010) Christoph Heesen et al. Multiple Sclerosis Journal
- Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
- (2010) J. J. Marriott et al. NEUROLOGY
- Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial
- (2010) R. T. Naismith et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- High-Dose Cyclophosphamide in the Treatment of Multiple Sclerosis
- (2009) Robert Jay Schwartzman et al. CNS Neuroscience & Therapeutics
- One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis
- (2009) L. Prosperini et al. EUROPEAN JOURNAL OF NEUROLOGY
- The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
- (2009) M. Hutchinson et al. JOURNAL OF NEUROLOGY
- Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy
- (2009) F. Reed Johnson et al. JOURNAL OF NEUROLOGY
- Concepts of induction and escalation therapy in multiple sclerosis
- (2009) Peter Rieckmann JOURNAL OF THE NEUROLOGICAL SCIENCES
- Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
- (2009) Richard K Burt et al. LANCET NEUROLOGY
- Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
- (2008) Chitra Krishnan et al. ARCHIVES OF NEUROLOGY
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
- (2008) L. K. Fisniku et al. BRAIN
- Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus
- (2008) Ines C. Kanter et al. EPILEPSIA
- Autologous haematopoietic stem-cell transplantation in multiple sclerosis
- (2008) Gianluigi Mancardi et al. LANCET NEUROLOGY
- Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis
- (2008) T Vollmer et al. Multiple Sclerosis Journal
- Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients
- (2008) J Río et al. Multiple Sclerosis Journal
- Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study
- (2008) E Cocco et al. Multiple Sclerosis Journal
- Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis
- (2008) Christine Lebrun et al. Multiple Sclerosis Journal
- Induction vs. escalation of therapy for relapsing Multiple Sclerosis: the evidence
- (2008) Mark S. Freedman NEUROLOGICAL SCIENCES
- Induction vs. escalating therapy in Multiple Sclerosis: practical implications
- (2008) Giancarlo Comi NEUROLOGICAL SCIENCES
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients
- (2007) E. Le Page et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started